Alliqua BioMedical Inc (ALQA):医療機器:M&Aディール及び事業提携情報

GlobalDataが発行した調査報告書(DATA904C7145)
◆英語タイトル:Alliqua BioMedical Inc (ALQA) - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C7145
◆発行会社(リサーチ会社):GlobalData
◆発行日:2018年10月
◆ページ数:49
◆レポート形式:英語 / PDF
◆納品方法:Eメール
◆調査対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。GlobalData社の概要及び新刊レポートはこちらでご確認いただけます。

【レポートの概要】

Summary
Alliqua BioMedical Inc (Alliqua BioMedical), formerly HepaLife Technologies Inc, is a regenerative technology company that builds a suite of regenerative solutions for wound and tissue repair. The company’s products comprise ultrasound healing therapy, human biologics, antimicrobial protection and hydration. Its contract manufacturing business unit provides custom hydrogels to the OEM market. Alliqua BioMedical develops and manufactures electron-beam cross-linked sheet gels for manufacturer of medical devices, cosmeceuticals, and other commercial product applications. The company’s customer service professionals assist with order placement, product training, and reimbursement. It operates through its GMP manufacturing facility in Langhorne. Alliqua BioMedical is headquartered in Langhorne, Pennsylvania, the US.

Alliqua BioMedical Inc (ALQA) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Alliqua BioMedical Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 6
Alliqua BioMedical Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 7
Alliqua BioMedical Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 8
Alliqua BioMedical Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 9
Alliqua BioMedical Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 10
Alliqua BioMedical Inc, Medical Equipment, Deal Details 11
Partnerships 11
BSN medical to Enter into Distribution Agreement with Alliqua BioMedical 11
Alliqua Enters Into Distribution Agreement With Sorbion 12
Alliqua BioMedical Amends Licensing Agreement with Celgene Cellular Therapeutics 13
Alliqua BioMedical Amends Licensing Agreement with Celgene Cellular Therapeutics 14
Alliqua Enters Into Licensing Agreement With Celgene Cellular Therapeutics For Wound Care Products 15
Equity Offering 16
Alliqua BioMedical Raises USD3.8 Million in Public Offering of Shares 16
Alliqua BioMedical Raises USD2.8 Million in Private Placement of Shares 18
Alliqua BioMedical Completes Public Offering of Shares for USD34.5 Million 19
Alliqua Completes Private Placement Of Shares For US$15 Million 21
Alliqua Completes Private Placement Of Shares For US$5.3 Million Upon Exercise Of Warrants 22
Alliqua Completes Private Placement Of Shares For US$6 Million 23
Alliqua Completes Private Placement Of Units For US$1 Million 25
Alliqua Completes Final Tranche Of Private Placement Of Shares For US$2 Million 26
Alliqua BioMedical Raises USD0.54 Million in Private Placement of Shares 27
Alliqua Completes Private Placement Of Shares For US$0.8 Million 28
Alliqua Completes Private Placement Of Units For US$0.3 Million 29
Alliqua Completes Private Placement Of Units For US$1.7 Million 30
Asset Transactions 31
Celularity Acquires Assets from Alliqua BioMedical for USD29 Million 31
Argentum Medical Acquires TheraBond and TheraBond 3D Antimicrobial Barrier Systems from Alliqua BioMedical for USD3.8 Million 32
Acquisition 33
Alliqua BioMedical Acquires Celleration for USD46.3 Million 33
Alliqua BioMedical Inc – Key Competitors 34
Alliqua BioMedical Inc – Key Employees 35
Alliqua BioMedical Inc – Locations And Subsidiaries 36
Head Office 36
Other Locations & Subsidiaries 36
Recent Developments 37
Financial Announcements 37
Nov 09, 2017: Alliqua BioMedical Reports Third Quarter of Fiscal Year 2017 Financial Results and Increases Fiscal Year 2017 Financial Outlook 37
Aug 10, 2017: Alliqua BioMedical Reports Second Quarter of Fiscal Year 2017 Financial Results 40
May 09, 2017: Alliqua BioMedical Reports First Quarter of Fiscal Year 2017 Financial Results 42
Apr 06, 2017: Alliqua BioMedical Announces Preliminary First Quarter Fiscal 2017 Revenue and Updates Fiscal Year 2017 Outlook 43
Mar 07, 2017: Alliqua BioMedical Reports Fourth Quarter and Fiscal Year 2016 Financial Results 44
Other Significant Developments 47
Nov 09, 2017: Alliqua BioMedical Engages Cowen to Assist in Evaluating Potential Strategic Alternatives 47
Sep 05, 2017: Alliqua BioMedical Announces the Sale of TheraBond 3D Antimicrobial Barrier Systems Product Line; Alliqua Updates Fiscal Year Outlook 48
Appendix 49
Methodology 49
About GlobalData 49
Contact Us 49
Disclaimer 49

List of Tables
Alliqua BioMedical Inc, Medical Equipment, Key Facts, 2017 2
Alliqua BioMedical Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
Alliqua BioMedical Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 6
Alliqua BioMedical Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 7
Alliqua BioMedical Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 8
Alliqua BioMedical Inc, Deals By Market, 2012 to YTD 2018 9
Alliqua BioMedical Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 10
BSN medical to Enter into Distribution Agreement with Alliqua BioMedical 11
Alliqua Enters Into Distribution Agreement With Sorbion 12
Alliqua BioMedical Amends Licensing Agreement with Celgene Cellular Therapeutics 13
Alliqua BioMedical Amends Licensing Agreement with Celgene Cellular Therapeutics 14
Alliqua Enters Into Licensing Agreement With Celgene Cellular Therapeutics For Wound Care Products 15
Alliqua BioMedical Raises USD3.8 Million in Public Offering of Shares 16
Alliqua BioMedical Raises USD2.8 Million in Private Placement of Shares 18
Alliqua BioMedical Completes Public Offering of Shares for USD34.5 Million 19
Alliqua Completes Private Placement Of Shares For US$15 Million 21
Alliqua Completes Private Placement Of Shares For US$5.3 Million Upon Exercise Of Warrants 22
Alliqua Completes Private Placement Of Shares For US$6 Million 23
Alliqua Completes Private Placement Of Units For US$1 Million 25
Alliqua Completes Final Tranche Of Private Placement Of Shares For US$2 Million 26
Alliqua BioMedical Raises USD0.54 Million in Private Placement of Shares 27
Alliqua Completes Private Placement Of Shares For US$0.8 Million 28
Alliqua Completes Private Placement Of Units For US$0.3 Million 29
Alliqua Completes Private Placement Of Units For US$1.7 Million 30
Celularity Acquires Assets from Alliqua BioMedical for USD29 Million 31
Argentum Medical Acquires TheraBond and TheraBond 3D Antimicrobial Barrier Systems from Alliqua BioMedical for USD3.8 Million 32
Alliqua BioMedical Acquires Celleration for USD46.3 Million 33
Alliqua BioMedical Inc, Key Competitors 34
Alliqua BioMedical Inc, Key Employees 35
Alliqua BioMedical Inc, Subsidiaries 36

List of Figures
Alliqua BioMedical Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
Alliqua BioMedical Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
Alliqua BioMedical Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
Alliqua BioMedical Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
Alliqua BioMedical Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 6
Alliqua BioMedical Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 7
Alliqua BioMedical Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 8
Alliqua BioMedical Inc, Medical Equipment, Deals by Market, 2012 to YTD 2018 9

【免責事項】
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ Alliqua BioMedical Inc (ALQA):医療機器:M&Aディール及び事業提携情報(Alliqua BioMedical Inc (ALQA) - Medical Equipment - Deals and Alliances Profile)]についてメールでお問い合わせはこちらでお願いします。

◆H&Iグローバルリサーチのお客様(例)◆